Literature DB >> 26446716

Role of Cardiac MRI in the Assessment of Cardiomyopathy.

Róisín B Morgan1, Raymond Kwong2.   

Abstract

OPINION STATEMENT: Combining the diagnostic utilities of cardiac structures, myocardial perfusion, and various tissue characterizing pulse sequence methods in matching scan planes within a single imaging session, cardiac magnetic resonance imaging (CMR) provides a novel interrogation of myocardial physiology and abnormal anatomy from various forms of cardiomyopathy. Establishment of technical imaging standards and clinical adaptation in the past years has helped recognize the distinguishing features of different cardiomyopathies, with CMR currently assuming a pivotal role in the diagnosis of cases of new-onset cardiomyopathy in experienced centers. Quantitative measurements such as ventricular volumes, myocardial iron content, and extent of late gadolinium enhancement can effectively monitor disease status, guide medical therapy, and impact patient outcomes in specific clinical settings. This chapter will aim to summarize these current CMR applications with case examples.

Entities:  

Keywords:  Cardiomyopathy; Gadolinium enhancement; Ischemia; Magnetic resonance; Scar; Viability

Year:  2015        PMID: 26446716     DOI: 10.1007/s11936-015-0410-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  96 in total

1.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

2.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

3.  CMR and amyloid cardiomyopathy: are we getting closer to the biology?

Authors:  Raymond Y Kwong; Michael Jerosch-Herold
Journal:  JACC Cardiovasc Imaging       Date:  2014-02

4.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

5.  Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction.

Authors:  Ahmed A Alsaileek; Imran Syed; James B Seward; Paul Julsrud
Journal:  J Magn Reson Imaging       Date:  2008-03       Impact factor: 4.813

6.  Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  Eri Watanabe; Siddique A Abbasi; Bobak Heydari; Otavio R Coelho-Filho; Ravi Shah; Tomas G Neilan; Venkatesh L Murthy; François-Pierre Mongeon; Chirag Barbhaiya; Michael Jerosch-Herold; Ron Blankstein; Hiroto Hatabu; Robert J van der Geest; William G Stevenson; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2014-10-06       Impact factor: 7.792

7.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

8.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

9.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

10.  Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study.

Authors:  Rui Xia; Fabao Gao; Jiayu Sun; Chunchao Xia; Zhangxue Hu; Yingkun Guo
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

View more
  2 in total

Review 1.  The role of myocardial wall thickness in atrial arrhythmogenesis.

Authors:  John Whitaker; Ronak Rajani; Henry Chubb; Mark Gabrawi; Marta Varela; Matthew Wright; Steven Niederer; Mark D O'Neill
Journal:  Europace       Date:  2016-05-31       Impact factor: 5.214

2.  Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.

Authors:  Da-Jun Hu; Jing Xu; Wei Du; Jian-Xin Zhang; Min Zhong; Ya-Nan Zhou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-26       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.